CUBICIN (daptomycin for injection) 500 mg, For Intravenous Use Only, Rx Only, Single use Vial, Manufactured for: Cubist Pharmaceuticals Inc., Lexington, MA 02421, USA, NDC 67919-011-01
Published November 5, 2014 · Recall initiated: August 8, 2014
Summary
FDA records drug Class I recall D-0229-2015, published November 5, 2014 and initiated August 8, 2014. Recalling firm: Cubist Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 371,879 Vials; Lot: Lot #'s: CDC203, Exp 12/2015; CDC207, Exp 01/2016; CDC213, Exp 02/2016; CDC217, Exp 03/2016; CDC226, Exp 04/2016; CDC234, CDC235, Exp 05/2016; CDC243, CDC246, Exp 07/2016. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at the bottom of the vial following reconstitution.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Cubist Pharmaceuticals, Inc.
- Distributor
- Nationwide and Puerto Rico.
- Lot
- Lot #'s: CDC203, Exp 12/2015; CDC207, Exp 01/2016; CDC213, Exp 02/2016; CDC217, Exp 03/2016; CDC226, Exp 04/2016; CDC234, CDC235, Exp 05/2016; CDC243, CDC246, Exp 07/2016.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVERSAPHARM INCORPORATED Ethambutol Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx Only, ManufacturedNovember 5, 2014
- FDACALCIUM GLUCONATE 2 gm (PF) PRESERVATIVE FREE in 100 mL Sodium Chloride 0.9% for Injection, Rx OnlyNovember 5, 2014
- FDAFentanyl/bupivacaine 3000 mcg/30 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy,November 5, 2014
- FDACUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals,October 8, 2014
- FDACUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals,June 18, 2014
- FDACubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, ManufacturedJanuary 29, 2014
Questions about this recall
Was CUBICIN (daptomycin for injection) 500 mg, For Intravenous Use Only, Rx Only, Single use Vial, Manufactured for: Cubist Pharmaceuticals Inc., Lexington, MA 02421, USA, NDC 67919-011-01 recalled?
Yes. FDA published recall D-0229-2015 on November 5, 2014. Reported hazard: Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at the bottom of the vial following reconstitution.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release